Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights GlobeNewswirePassage Bio Cuts Losses And Gains Analysts’ Confidence FinimizePassage Bio, Inc. Announces Active Enrollment in upliFT-D Study and Regulatory Alignment with FDA Quiver QuantitativePassage Bio Reports Q3 Financial Results and Updates TipRanksPassage Bio (PASG) Advances PBFT02 Clinical Trials and FDA Discu GuruFocus
